Taken together, these observations suggest that the LMO1 +57 region functions as a transcriptional enhancer element in T-ALL cells, and may utilise known T-ALL oncogenic transcription factors such as SCL to mediate its activity. This evidence concerns the gene TAL1 and acute lymphoblastic leukemia.